Last update 20 Mar 2025

Lemzoparlimab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Anti-CD47 antibody ( I-Mab)
+ [1]
Target
Action
inhibitors
Mechanism
CD47 inhibitors(Cluster of differentiation 47 inhibitors)
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 2
China
08 May 2021
Adult Acute Myeloblastic LeukemiaPhase 2
China
25 Mar 2020
Refractory acute myeloid leukemiaPhase 1
China
25 Mar 2020
Relapsing acute myeloid leukemiaPhase 1
China
25 Mar 2020
Diffuse Large B-Cell LymphomaPhase 1
United States
16 Apr 2019
Myelodysplastic SyndromesDiscovery
China
30 Mar 2023
Advanced Malignant Solid NeoplasmDiscovery
China
30 Dec 2021
MelanomaDiscovery
China
30 Dec 2021
Squamous Cell Carcinoma of Head and NeckDiscovery
China
30 Dec 2021
Stomach CancerDiscovery
China
30 Dec 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
53
-
(swcifnivoc) = ssgssmasul cyebeqhclf (spchploklx )
Positive
10 Sep 2022
(initial treatment ≥ 4 mo)
(tlytxjeovx) = jgbmqltuln zsememheky (xtgxqvmpla )
Phase 1
9
Lemzoparlimab+Rituximab
(jdafkrnyad) = nbjfxwhmnz ohpmonspoh (nfdbcfnvha )
Positive
14 Dec 2021
Phase 1
20
iuyrvrizgr(qswelopkki) = vuhpucbgri ncagncqhmg (pwncdrrkqj )
Positive
10 Dec 2020
Phase 1
5
(kvktxuvsea) = none thnmjgxmwq (iopdlvjvtf )
Positive
05 Nov 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free